Technical Analysis for IBO - Impact BioMedical, Inc.

Grade Last Price % Change Price Change
B 2.68 19.11% 0.43
IBO closed up 19.11 percent on Friday, November 1, 2024, on 77 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Calm After Storm Range Contraction 19.11%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 18 hours ago
Rose Above Upper Bollinger Band about 18 hours ago
1.5x Volume Pace about 18 hours ago
Down 5% about 18 hours ago
Down 3% about 18 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Impact BioMedical, Inc. Description

Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. The company was incorporated in 2018 and is based in Houston, Texas.


Classification

Sector: Healthcare
Industry: Biotechnology

Is IBO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.0
52 Week Low 1.22
Average Volume 108,669
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 1.70
10-Day Moving Average 1.95
Average True Range 0.31
RSI (14) 70.15
ADX 26.96
+DI 30.43
-DI 14.54
Chandelier Exit (Long, 3 ATRs) 1.76
Chandelier Exit (Short, 3 ATRs) 2.16
Upper Bollinger Bands 2.46
Lower Bollinger Band 0.93
Percent B (%b) 1.14
BandWidth 90.05
MACD Line 0.05
MACD Signal Line -0.11
MACD Histogram 0.1567
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.56
Resistance 3 (R3) 3.47 3.09 3.42
Resistance 2 (R2) 3.09 2.86 3.13 3.37
Resistance 1 (R1) 2.88 2.72 2.98 2.97 3.32
Pivot Point 2.50 2.50 2.55 2.54 2.50
Support 1 (S1) 2.29 2.27 2.40 2.39 2.04
Support 2 (S2) 1.91 2.13 1.95 1.99
Support 3 (S3) 1.70 1.91 1.94
Support 4 (S4) 1.80